Orion Laboratories Pty Ltd T/A Perrigo Australia
Regulatory activities for this sponsor.
Loading...
Sponsor content
313 result(s) found, displaying 61 to 70
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2021
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia